Companies / Sorriso Pharmaceuticals
Sorriso Pharmaceuticals
Sandy, United States
Sorriso Pharmaceuticals is developing novel oral antibodies to address unmet needs in immune-mediated disease.
Sorriso Pharmaceuticals, based in Sandy, United States, has 2 investors on file, among them Biovision Ventures and NEA. Its site was last checked 13 Nov 2026: site answers.
SEC Form D filings
1 filingFiled by Sorriso Pharmaceuticals, Inc. with the SEC. A Form D reports a private offering; it is not a priced round.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
More from Biovision Ventures
14 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (100%).
See Biovision Ventures' full profile · Who invests alongside it
More from NEA
528 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (22%), AI & Machine Learning (19%), Fintech (10%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Sorriso Pharmaceuticals and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Biovision Ventures adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/sorrisopharma.com/investors
# also
GET /v1/companies/sorrisopharma.com
GET /v1/companies/sorrisopharma.com/news